Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 2/20 | 0.32 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 3/20 | 0.30 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.30 |
| ▸ | CDK1 | P06493 | 2/20 | 0.30 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.30 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.30 |
| ▸ | QPCT | Q16769 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL782446 | 0.95 | MDM2 (0.32) | MDM2DNMT1HDAC4PDE4BALDH1A1 | |
| SCHEMBL10014086 | 0.94 | MDM2 (0.32) | MDM2DNMT1HDAC4PDE4BALDH1A1 | |
| SCHEMBL12647531 | 0.93 | PDK2 (0.32) | MDM2HDAC4PDE4BALDH1A1MAPK1 | |
| SCHEMBL8819147 | 0.93 | PGR (0.35) | DNMT1PDE4BALDH1A1PDK2PGR | |
| SCHEMBL783405 | 0.90 | HDAC4 (0.35) | HDAC4GSK3B | |
| SCHEMBL12647524 | 0.89 | PDK2 (0.35) | MDM2PDK2PGR | |
| SCHEMBL28664747 | 0.89 | PDK2 (0.34) | DNMT1PDE4BALDH1A1MAPK1PDK2 | |
| SCHEMBL30860151 | 0.89 | PDK2 (0.34) | DNMT1PDE4BALDH1A1MAPK1PDK2 | |
| SCHEMBL15806114 | 0.88 | NR1H2 (0.32) | ALDH1A1GSK3BQPCT | |
| SCHEMBL10014087 | 0.88 | L3MBTL1 (0.41) | HDAC4ALDH1A1PDK2PGRGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9233923-B2 | Organic compounds for organic electronic devices and terminals | DUK SAN NEOLUX CO., LTD. (KR) | 2016-01-12 | — | — | US | disclosed |
| US-9233923-B2 | Organic compounds for organic electronic devices and terminals | DUK SAN NEOLUX CO., LTD. (KR) | 2016-01-12 | — | — | US | disclosed |
| US-20120018717-A1 | ORGANIC ELECTRONIC DEVICE, COMPOUNDS FOR SAME, AND TERMINAL | DUKSAN HIGH METAL CO., LTD. (KR) | 2012-01-26 | — | — | US | disclosed |
| US-20120018717-A1 | ORGANIC ELECTRONIC DEVICE, COMPOUNDS FOR SAME, AND TERMINAL | DUKSAN HIGH METAL CO., LTD. (KR) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120018717-A1 | ORGANIC ELECTRONIC DEVICE, COMPOUNDS FOR SAME, AND TERMINAL | OR10J3, OR51E2, ESR1 | MDM2 875/4885DNMT1 80/4885HDAC4 4419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.